Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma

标题
Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma
作者
关键词
Bevacizumab, Pancreatic Ductal Adenocarcinoma, Complete Pathologic Response, Gross Tumor Volume, Advanced Pancreatic Cancer
出版物
ANNALS OF SURGICAL ONCOLOGY
Volume 20, Issue 12, Pages 3787-3793
出版商
Springer Nature
发表日期
2013-07-31
DOI
10.1245/s10434-013-3161-9

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now